The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date clinical trials
6 indexed studies · 4 currently recruiting
- CompletedPhase I
Deferred registration: Fortrea code 780279
This is an early-stage (Phase 1) clinical trial involving babies under one year of age, run by research organisation Fortrea. Full medical details about the condition and treatment are currently delayed with permission from the UK Health Research Authority. Complete study information will be made public once this delay ends.
For: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry dateUnited Kingdom · England - RecruitingPhase I
Deferred registration - ICON Clinical (UK) Limited/Newcastle Upon Tyne Hospitals NHS Foundation Trust Code: BP45361
This is an early-stage Phase 1 clinical trial taking place in the UK with Newcastle Upon Tyne Hospitals NHS Foundation Trust. Full details about the study are temporarily withheld under official UK research rules. The study plans to include men and women aged between 40 and 75 years.
For: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.United Kingdom · England · Austria - CompletedPhase I
Deferred registration: Fortrea code: 780587
This is an early-stage (Phase 1) clinical trial organised by the research organisation Fortrea for adults aged 35 to 55. Specific details about the medicine and condition are temporarily kept private, with permission from the UK Health Research Authority, and will be made public once this deferral period ends.
For: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.United Kingdom · England - Not yet recruitingPhase II
Deferred registration - AstraZeneca/United Kingdom Code: D7260C00014
This is an early-stage UK clinical trial run by AstraZeneca for babies under one year old. The Health Research Authority has agreed to delay publishing the full details about the condition and treatment for now. Complete information will be made public once this temporary delay ends.
For: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.United Kingdom · England - RecruitingPhase I
Deferred registration - Klear Bio Code: KLR003-Clin-004
This is an early-stage Phase I clinical trial sponsored by Klear Bio for adults aged 18 to 65. The full study details and medical conditions are temporarily withheld under an official deferral approved by the UK Health Research Authority. Complete information will be published once the deferral period ends.
For: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry dateUnited Kingdom · England · Netherlands - RecruitingPhase I
Phase I study of PM534 to patients with advanced solid tumors
This early-stage study is looking at a new medicine called PM534 for people with advanced cancers. More details about the study will be available soon, as the Health Research Authority has given more time to provide information. It's open to adults aged 18 to 100, regardless of gender.
For: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.United Kingdom · England · Spain